Pemafibrate for prevention of atherosclerotic diseases in patients with ischemic stroke or transient ischemic attack
Not Applicable
Recruiting
- Conditions
- ischemic stroke, transient ischemic attack
- Registration Number
- JPRN-UMIN000040619
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. Contraindications for pemafibrate (e.g., allergy to the drug, severe kidney dysfunction, pregnancy etc.) 2. Patients who have a history of or plan to undergo carotid endarterectomy/carotid stenting 3. Patients who had received pemafibrate before index event
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method